Authors:
CATALONA WJ
PARTIN AW
SLAWIN KM
BRAWER MK
FLANIGAN RC
PATEL A
RICHIE JP
DEKERNION JB
WALSH PC
SCARDINO PT
LANGE PH
SUBONG ENP
PARSON RE
GASIOR GH
LOVELAND KG
SOUTHWICK PC
Citation: Wj. Catalona et al., USE OF THE PERCENTAGE OF FREE PROSTATE-SPECIFIC ANTIGEN TO ENHANCE DIFFERENTIATION OF PROSTATE-CANCER FROM BENIGN PROSTATIC DISEASE - A PROSPECTIVE MULTICENTER CLINICAL-TRIAL, JAMA, the journal of the American Medical Association, 279(19), 1998, pp. 1542-1547
Authors:
HINKEL A
GITLITZ BJ
KABOO R
TSO CL
DEKERNION JB
FIGLIN RA
BELLDEGRUN A
Citation: A. Hinkel et al., A NOVEL TECHNIQUE FOR GENERATING TUMOR LYSATE (TULY) LOADED DENDRITICCELLS (DC) FOR USE IN TUMOR VACCINE ADOPTIVE IMMUNOTHERAPY OR RENAL-CELL CANCER/, The Journal of urology, 159(5), 1998, pp. 652-652
Authors:
CANGIANO TG
DOREY F
NAITOH J
PATEL A
DEKERNION JB
Citation: Tg. Cangiano et al., INTRAOPERATIVE FROZEN-SECTION MONITORING OF NERVE SPARING RADICAL RETROPUBIC PROSTATECTOMY, The Journal of urology, 159(5), 1998, pp. 838-838
Authors:
YANG RM
NAITOH J
MURPHY M
WANG HJ
PHILLIPSON J
DEKERNION JB
LODA M
REITER RE
Citation: Rm. Yang et al., LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE-CANCER, The Journal of urology, 159(3), 1998, pp. 941-945
Authors:
STEGER GG
GNANT MF
DJAVANMARD MP
MADER RM
JAKESZ R
PIERCE W
DEKERNION JB
FIGLIN R
BELLDEGRUN A
Citation: Gg. Steger et al., THE IN-VITRO EFFECTS OF INTERLEUKIN-12 UPON TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM RENAL-CELL CARCINOMA, Journal of cancer research and clinical oncology, 123(6), 1997, pp. 317-324
Citation: J. Naitoh et al., PREDICTING PATHOLOGICAL STAGE OF LOCALIZED PROSTATE-CANCER, JAMA, the journal of the American Medical Association, 278(12), 1997, pp. 980-981
Citation: Jb. Dekernion, THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POSTPROSTATECTOMY PROSTATE-SPECIFIC ANTIGEN LEVEL - COMMENT, The Journal of urology, 158(4), 1997, pp. 1439-1439
Citation: A. Patel et al., RECURRENCE PATTERNS AFTER RADICAL RETROPUBIC PROSTATECTOMY - CLINICALUSEFULNESS OF PROSTATE-SPECIFIC ANTIGEN DOUBLING TIMES AND LOG SLOPE PROSTATE-SPECIFIC ANTIGEN, The Journal of urology, 158(4), 1997, pp. 1441-1445
Authors:
MARKS LS
PARTIN AW
GORMLEY GJ
DOREY FJ
SHERY ED
GARRIS JB
SUBONG ENP
STONER E
DEKERNION JB
Citation: Ls. Marks et al., PROSTATE TISSUE COMPOSITION AND RESPONSE TO FINASTERIDE IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA, The Journal of urology, 157(6), 1997, pp. 2171-2178
Citation: Jb. Dekernion, EVALUATION AND MANAGEMENT OF PARASTOMAL HERNIA IN ASSOCIATION WITH CONTINENT URINARY-DIVERSION - COMMENT, The Journal of urology, 157(5), 1997, pp. 1632-1632
Authors:
PANG S
DANNULL J
KABOO R
XIE YM
TSO CL
MICHEL K
DEKERNION JB
BELLDEGRUN AS
Citation: S. Pang et al., IDENTIFICATION OF A POSITIVE REGULATORY ELEMENT RESPONSIBLE FOR TISSUE-SPECIFIC EXPRESSION OF PROSTATE-SPECIFIC ANTIGEN, Cancer research, 57(3), 1997, pp. 495-499
Authors:
BELLDEGRUN A
TSO CL
KABOO R
PANG S
PIERCE W
DEKERNION JB
FIGLIN R
Citation: A. Belldegrun et al., NATURAL IMMUNE REACTIVITY-ASSOCIATED THERAPEUTIC RESPONSE IN PATIENTSWITH METASTATIC RENAL-CELL CARCINOMA RECEIVING TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2-BASED THERAPY, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 149-161
Authors:
MARKS LS
DOREY FJ
RHODES T
SHERY ED
RITTENHOUSE H
PARTIN AW
DEKERNION JB
Citation: Ls. Marks et al., SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER TRANSURETHRAL RESECTION OF PROSTATE - A LONGITUDINAL CHARACTERIZATION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA, The Journal of urology, 156(3), 1996, pp. 1035-1039
Authors:
CATALONA WJ
HUDSON MA
SCARDINO PT
RICHIE JP
AHMANN FR
FLANIGAN RC
DEKERNION JB
RATLIFF TL
KAVOUSSI LR
DALKIN BL
WATERS WB
MACFARLANE MT
SOUTHWICK PC
Citation: Wj. Catalona et al., SELECTION OF OPTIMAL PROSTATE-SPECIFIC ANTIGEN CUTOFFS FOR EARLY DETECTION OF PROSTATE-CANCER - RECEIVER OPERATING CHARACTERISTIC CURVES - REPLY, The Journal of urology, 155(4), 1996, pp. 1396-1396
Authors:
SOKOLOFF MH
TSO CL
KABOO R
TANEJA S
PANG S
DEKERNION JB
BELLDEGRUN AS
Citation: Mh. Sokoloff et al., IN-VITRO MODULATION OF TUMOR PROGRESSION-ASSOCIATED PROPERTIES OF HORMONE-REFRACTORY PROSTATE CARCINOMA CELL-LINES BY CYTOKINES, Cancer, 77(9), 1996, pp. 1862-1872